MENLO PARK, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Geron Corporation GERN will announce its financial results for the second quarter ended June 30, 2016, on Wednesday, August 3, 2016, after the market close. Geron's management will also host a conference call for analysts and investors on Wednesday, August 3, 2016, at 4:30 p.m. Eastern Time to discuss the company's second quarter results and recent events.
Participants can access the conference call live via telephone by dialing 877-303-9139 (U.S.); 760-536-5195 (international). The conference ID is 50542873. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/dmhjza72/lan/en. The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through September 2, 2016.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.